Expression of insulin‐like growth factor‐1 receptor in circulating tumor cells of patients with breast cancer is associated with patient outcomes

In patients with breast cancer, markers of aggressiveness such as dysregulation of the insulin‐like growth factor receptor (IGF1R) system and E‐cadherin loss are commonly observed. Reduced IGF1R expression is correlated with decreased E‐cadherin levels and increased cell motility. We assessed IGF1R...

Descripción completa

Detalles Bibliográficos
Autores principales: Spiliotaki, Maria, Mavroudis, Dimitris, Kokotsaki, Maria, Vetsika, Eleni‐Kyriaki, Stoupis, Ioannis, Matikas, Alexios, Kallergi, Galatea, Georgoulias, Vassilis, Agelaki, Sofia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5748482/
https://www.ncbi.nlm.nih.gov/pubmed/28766847
http://dx.doi.org/10.1002/1878-0261.12114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5748482/
https://www.ncbi.nlm.nih.gov/pubmed/28766847
http://dx.doi.org/10.1002/1878-0261.12114

Ejemplares similares